Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In connection with the transition to the 8th version of the classification of lung cancer according to the TNM system, there are currently no precise epidemiological data on stage III NSCLC, clinical characteristics of patients in this group, approaches to therapy and treatment results in the Russian Federation. The published statistics only provide information on the overall incidence of stage III lung, trachea and bronchial cancer, which is about 40%. This observational study will make it possible to characterize the Russian population of stage III non-small cell lung cancer patients, approaches to choosing a treatment option for stage III NSCLC and the outcomes of this treatment in real clinical practice.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Examine clinical and morphological groups |
Percentage: a. Surgery v. Chemotherapy -Diagnostic algorithm: a. Morphological verification frequency b. The frequency of confirmation of metastatic lesions within the thoracic lymph nodes c. F | 10/01/2023 |
| Measure | Description | Time Frame |
|---|---|---|
| Explore clinical approaches |
| 10/01/2023 |
| Diagnostic algorithm: |
| Measure | Description | Time Frame |
|---|---|---|
| -Evaluate the frequency of decision-making as a standard practice vs with an individual decision |
| 10/01/2023 |
Inclusion Criteria:
- stage III non-small cell lung cancer
Exclusion Criteria:
- the rest of the disease stage
Not provided
Not provided
patients with morphologically proven stage III non-small cell lung cancer
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Konstantin Laktionov, Professor | Contact | +7-903-170-97-95 | lkoskos@mail.ru | |
| Valeriy Breder, Leading Researcher | Contact | +7-903-199-07-55 | vbreder@yandex.ru |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| National Medical Research Center of Oncology. N. N. Blokhin | Recruiting | Moscow | 115478 | Russia |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002289 | Carcinoma, Non-Small-Cell Lung |
| ID | Term |
|---|---|
| D002283 | Carcinoma, Bronchogenic |
| D001984 | Bronchial Neoplasms |
| D008175 | Lung Neoplasms |
| D012142 | Respiratory Tract Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
v. from a variant of molecular genetic disorders
| 10/01/2023 |
| Percentage of treatment options | from functional status
| 10/01/2023 |
| D013899 |
| Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |